Further research is warranted to clarify the causal relationships between ANO1 deficiency, thalamocortical dysfunction, and schizophrenia-like behaviors, and to explore whether pharmacological interventions can effectively normalize these alterations. The gene discussed is ANO1; the disease is schizophrenia.